Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.

Clinical trial NCT02053818 · COMPLETED

Trial details

NCT number: NCT02053818
Sponsor: Aarhus University Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ischaemic Heart Disease Aortic Stenosis

Start date: 2011-08-01
Primary completion: 2015-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.